Analysis Topic: Companies Analysis
The analysis published under this topic are as follows.Friday, July 13, 2012
Three Reasons Why Utility Stocks Are A Bargain Right Now / Companies / US Utilities
US Regulatory Environment Remains Levelheaded
Utilities’ ability to stay strong depends on regulators granting a fair return on investment. The alternative, by contrast, is the surest way to undermine both shareholder returns and long-term system reliability.
Read full article... Read full article...
Wednesday, July 11, 2012
Four Debt Free Companies to Own Even if Markets Crash / Companies / Investing 2012
Keith Fitz-Gerald writes: Many investors remain on the sidelines under the impression that every company has been stopped in its tracks by the financial crisis. Somehow they've convinced themselves there's nothing worth owning.
The problem is it's just not true. Companies that carry little or no debt are kicking butt and will continue to do so even if the markets stumble.
Read full article... Read full article...
Tuesday, July 10, 2012
Prepare Your Stocks Portfolio for Recession 2012 with Dividend Payers / Companies / Dividends
Martin Hutchinson writes: Successful investing is a bit like connecting the dots. Put enough of them together and they begin to form a picture.
Unfortunately, today's dots are pointing towards a recession.
With first-quarter GDP growth under 2% and a whole host of indicators moving in the wrong direction, it looks as though the U.S. economy has stalled.
Read full article... Read full article...
Monday, July 02, 2012
With Internet Traffic Set to Zoom, Cisco is the Stock You Need to Buy Now / Companies / Tech Stocks
William Patalon III writes: Back on May 9, Internet bellwether Cisco Systems Inc. (Nasdaq: CSCO) warned investors of a weaker-than-expected outlook for the current quarter - thanks to what CEO John Chambers described as a "cautious" spending environment for networking gear.
Cisco's shares were trashed - as were many other tech-sector stocks.
Read full article... Read full article...
Friday, June 29, 2012
Google Nexus 7 Tablet Fails to Beat Rivals / Companies / Google
David Zeiler writes: While impressive in many ways, the Google Inc. (Nasdaq: GOOG) Nexus 7 tablet unveiled today (Wednesday) will struggle in a market already teeming with offerings from other tech titans.
Key competitors include tablet market leader Apple Inc. (Nasdaq: AAPL), Samsung Electronics Co. (PINK: SSNLF), Amazon.com (Nasdaq: AMZN) and as of last week, Microsoft Corp. (Nasdaq: MSFT).
Read full article... Read full article...
Wednesday, June 27, 2012
Four Recession-Proof Stocks Investing for 2012 and Beyond / Companies / Investing 2012
Don Miller writes: Despite the efforts of Federal Reserve Chairman Ben Bernanke and his cohorts, it looks like gridlock in Congress will push us into a recession in 2013, if not sooner.
In case you haven't been paying attention, "Taxmageddon," and election-year politics have driven the economy to the edge of a "fiscal cliff." This means the start of next year, unless drastic measures are taken in Washington, is looking precarious for investors.
Read full article... Read full article...
Monday, June 25, 2012
The Glory Days for U.S. Farms are Far From Over / Companies / Agricultural Commodities
Michael A. Robinson writes: Many Americans view farming as one of the last bastions of low tech.
It's not hard to see why. These days you can use your tablet computer for a video chat session while your car parks itself.
How on earth could crops ever compete with that?
Read full article... Read full article...
Friday, June 22, 2012
Did RBS Hit the Greece Election Eurogeddon Bank Holiday Panic Button by Mistake? / Companies / Credit Crisis 2012
RBS Bank and its subsidiary Nat West have effectively been closed all week to all of their customers, freezing them out of control of day to day banking operations. The shutdown appears fairly complete, with thus far RBS being unable to get the system going again.
Read full article... Read full article...
Friday, June 22, 2012
Corporate Earnings Growth Spotlight: Novartis AG / Companies / Corporate Earnings
Swiss drugmaker Novartis AG (NVS) in April reported first-quarter 2012 earnings per share (EPS) of $1.27, down from the $1.4 posted a year earlier. First-quarter revenue fell to $13.7 billion from last year’s $14 billion. Earnings dropped 18 percent, to $2.3 billion.
Read full article... Read full article...
Thursday, June 21, 2012
The Best of the Best Dividend-Paying Stocks / Companies / Dividends
Ben Gersten writes: Over the past few years there have been unprecedented swings in the major indexes, scaring some investors out of the markets altogether.
What people don't realize is that successful investing is a matter of continuous performance, not instantaneous performance.
Read full article... Read full article...
Thursday, June 21, 2012
Investing in Graphene "Miracle Material" for Profit / Companies / Technology
Larry D. Spears writes: Last December, Money Morning technology specialist Michael A. Robinson told you about a radical new material that would soon have a pervasive impact on the U.S. economy - and the entire human race.
Robinson detailed how this new material is so powerful and versatile, it's going to play a key role in new products for the U.S. military, leading tech companies, and medical researchers.
Read full article... Read full article...
Thursday, June 21, 2012
How the Apple iPhone Will Save Millions of Lives / Companies / Tech Stocks
Michael A. Robinson writes: It's hard to believe, but it's true. The iPhone turns five years old next week.
Since its official launch on June 29, 2007, Apple Inc. (Nasdaq: AAPL) has sold well over 180 million iPhones. Hands down, it's the most successful mobile phone ever launched.
Read full article... Read full article...
Thursday, June 21, 2012
Of Course I Would Like to be CEO of Goldman Sachs / Companies / Banking Stocks
BLOOMBERG EXCLUSIVE: Gary Cohn, president and COO of Goldman Sachs, appeared on Bloomberg TV's "Market Makers" today with Erik Schatzker and said, "of course I would like to be CEO of Goldman Sachs." He also said, "I can tell you for sure it is not good for us to have JPMorgan going through what they're going though."
Read full article... Read full article...
Monday, June 18, 2012
Should You Short Stocks? Here's How, Along With Four Suggestions... / Companies / Company Chart Analysis
Keith Fitz-Gerald writes: With Europe on the ropes and the U.S. economy in shambles, it's important to remember that there are two sides to every trade.
Tapping into upward momentum alone is not the only way to profit. Markets can and do head south on a regular basis. Investors who fail to grasp this are leaving a lot of money on the table.
Read full article... Read full article...
Sunday, June 17, 2012
The Right Regulatory Formula for Markets / Companies / Market Regulation
Last weekend, I had the chance to experience the thrill of Formula 1 Grand Prix du Canada in Montreal. Seeing the incredible fluidity and flexibility of every race car, it got me thinking about how F1 has evolved over the past 60 years. Cars are now aerodynamic like a jet fighter, designed with wings that use the same principle as an aircraft and tires that withstand tremendous forces. Even with all these incredible advancements in technology, rules and regulations have been streamlined to reduce costs and improve safety. Since 1994, there hasn't been a fatal accident in the motorsport.
Read full article... Read full article...
Friday, June 15, 2012
Intel Stock Market Dynamics / Companies / Company Chart Analysis
They say the proof is in the pudding. Upon first encountering the proposed market cycle matrix of the late market analyst PQ Wall, from the Kondratieff long wave down to the 20-week cycle, it was dismissed by this author and fellow market cycle researcher. It simply could not be true. The conclusions were clearly the results of an obsessive-compulsive disorder in an otherwise gifted financial market analyst. Years later, coming to a frustrating dead end with the work of Harvard economist and cycle theorist Joseph Schumpeter, and his smaller cycle work presented in Business Cycles, PQ's claims were studied more closely. The results of further inquiry into the mind and market matrix methods of PQ Wall were shocking. PQ Wall has changed market cycle theory forever, and his maverick thinking may hold the keys to even greater mysteries of the universe.
Read full article... Read full article...
Thursday, June 14, 2012
Healthcare Stocks: What Happens if Obamacare is Overturned / Companies / Healthcare Sector
David Zeiler writes: With the Supreme Court ruling on President Barack Obama's healthcare reform law just three weeks away, investors in healthcare stocks need to be prepared.
While some are confident the Supreme Court will rule in favor of the Patient Protection and Affordable Care Act, a rejection of the law -- or at least of the mandate requiring everyone to buy insurance -- may be more likely.
Read full article... Read full article...
Wednesday, June 13, 2012
Is Tata Motors the New GM? / Companies / US Auto's
G.S. Early writes: As far as prestigious SUVs go, the Land Rover badge has been a mainstay in the road-less hinterlands for decades.
Yet it has taken years for someone to actually get the formula right. BMW tried. Then Ford.
But neither one of them could quite get it.
Read full article... Read full article...
Wednesday, June 13, 2012
Another Blow to Facebook Stock Investors / Companies / Tech Stocks
Ben Gersten writes: Facebook (Nasdaq: FB) and its struggling stock price have been in the spotlight since the company's IPO, but rarely for good news. This week started no differently.
Besides its poor stock performance, Facebook already has been blamed for halting this year's IPO market. There hasn't been an IPO since Facebook debuted on May 17.
Read full article... Read full article...
Wednesday, June 13, 2012
How to Spot the Next Hot Biotech Stock / Companies / BioTech
Keith Fitz-Gerald writes: It's not enough to understand long- term trends, today's investors need to have the ability to move quickly, especially when it comes to biotech stocks.
But here is what you need to know about biotech stocks: none of them are created equal.
Read full article... Read full article...